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A photodynamic technique for human breast cancer detection founded upon the ability of tumour cells to rapidly accumulate the
fluorescent product protoporphyrin IX (PpIX) has been applied to transgenic mouse models of mammary tumorigenesis. A major
goal of this investigation was to determine whether mouse mammary tumours are reliable models of human disease in terms of PpIX
accumulation, for future mechanistic and therapeutic studies. The haeme substrate 5-aminolevulinic acid (5-ALA) (200mgkg
1) was
administered to mouse strains that develop mammary tumours of various histological subtypes upon expression of the transgenic
oncogenes HRAS, Polyoma Virus middle T antigen, or Simian Virus 40 large T antigen in the mammary gland. Early neoplastic lesions,
primary tumours and metastases showed consistent and rapid PpIX accumulation compared to the normal surrounding tissues, as
evidenced by red fluorescence (635nm) when the tumours were directly illuminated with blue light (380–440nm). Detection of
mouse mammary tumours at the stage of ductal carcinoma in situ by red fluorescence emissions suggests that enhanced PpIX
synthesis is a good marker for early tumorigenic processes in the mammary gland. We propose the mouse models provide an ideal
experimental system for further investigation of the early diagnostic and therapeutic potential of 5-ALA-stimulated PpIX accumulation
in human breast cancer patients.
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Synthesis of the fundamental co-factor haeme occurs as a
multistep biochemical pathway within the cytoplasmic and
mitochondrial compartments of all mammalian cells. Haeme
synthesis shows controlled and complex regulation with promi-
nent substrate inhibition at the first step of 5-aminolevulinic acid
(5-ALA) production (Ponka, 1999). Exogenous administration of
5-ALA overrides product inhibition, and leads to increased
synthesis of the haeme precursors. It is well documented that
neoplastic cells derived from multiple human tumour types show
an exaggerated capacity for haeme precursor synthesis following
5-ALA exposure relative to normal cells, although the exact
contribution to tumour development remains unclear (Collaud
et al, 2004). Tumours of the skin, bladder, oesophagus, oral cavity,
colon, breast, ovary, cervix, leukocytes and brain accumulate the
fluorescent haeme precursor protoporphyrin IX (PpIX) following
5-ALA administration (Stummer et al, 1998; af Klinteberg et al,
1999; Chen et al, 2001; Ladner et al, 2001; Moesta et al, 2001; Betz
et al, 2002; Bogaards et al, 2002; Olivo et al, 2003; Stepinac et al,
2003; Lo ¨ning et al, 2004). In the case of human colon cancers and
their metastases, it was observed that PpIX concentrations were
elevated compared to the normal surrounding tissues without
exogenous 5-ALA administration (Moesta et al, 2001). Investiga-
tions to address the mechanism of enhanced PpIX synthesis have
focussed on the activity of the haeme synthesis enzymes, and
suggest that increased activity of the enzymes involved in
porphyrin synthesis – 5-ALA dehydratase and hydroxymethylbi-
lane synthase – combined with reduced activity of ferrochelatase to
generate haeme from PpIX, may contribute to the net PpIX
accumulation response of tumours (Navone et al, 1990; Hinnen
et al, 1998; Krieg et al, 2002). Additional factors that influence
PpIX accumulation may relate to the tumour micro-environment
(pH, vascularisation) or other properties of tumour cells that could
impact upon haeme synthesis, such as altered mitochondrial
function, or transport of 5-ALA, porphyrin intermediates, and iron
(Collaud et al, 2004).
The general property of PpIX loading by tumour cells, either
inherently, or following 5-ALA dosing, has stimulated numerous
basic research and clinical studies for potential therapeutic and
diagnostic uses. PpIX is a natural photosensitiser that generates
reactive oxygen intermediates following excitation with 635nm
light. Thus 5-ALA-stimulated PpIX loading has been evaluated for
photodynamic therapy (PDT) to eradicate tumour cells (Peng et al,
1992; Hua et al, 1995; Casas et al, 2001; Otake et al, 2003).
Similarly, PpIX loading stimulated by administration of 5-ALA was
investigated for the purpose of photodynamic detection (PDD) of
tumour cells (Bedwell et al, 1992; Van Hillegersberg et al, 1992).
This strategy utilises blue light excitation (380–440nm) to induce
red fluorescent emissions (635nm) from the tumour cells that
concentrate PpIX, and has been put to practical use to identify
margins of neoplasia during exploratory or tumour de-bulking
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sFigure 1 Digital image capture of PpIX-stimulated red fluorescence in tumours of three mammary tumour-bearing transgenic strains 1h following in vivo
administration of 200mgkg
1 ALA, with corresponding H&E stained histological sections. (A, B) Red fluorescence in a papillary adenocarcinoma of a
WapTag1 female (77 weeks) (20). (C, D) HRAS male mammary tumour (11 weeks) showing prominent fluorescence and solid carcinoma histology
(20); (E, F) Fluorescent multifocal tumours of a PyVT female (5 weeks) with solid carcinoma histology (20). Scale bar represents 1mm.
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ssurgery (Kriegmair et al, 1999; Holtl et al, 2001; Mayinger et al,
2001; Bogaards et al, 2005).
5-ALA-stimulated PpIX loading for use in PDD has shown great
promise for human breast cancer, both in its application to define
primary tumour margins during surgical removal, and for the
identification of axillary lymph node metastases; (Ladner et al,
2001; Frei et al, 2004). We sought to examine the potential for 5-
ALA-stimulated PpIX loading in mammary tumours that develop
in three well-characterised transgenic models of mammary
tumorigenesis. The purpose of this investigation was three-fold:
(1) to establish whether transgenic mouse mammary tumours are
reliable models of human disease in terms of PpIX accumulation
following 5-ALA administration, (2) to determine if the PpIX
accumulation response was similar in each oncogenic model of
tumorigenesis and (3) to develop an animal model for the study of
the cellular and molecular mechanisms of enhanced PpIX
accumulation. Our investigation revealed that rapid and significant
PpIX loading occurred not only in primary tumours, but also in
metastases and very early neoplastic lesions from the different
transgenic models. We suggest that ALA-stimulated PpIX loading
of early cancerous lesions of human mammary ducts will similarly
contribute to early detection of human breast cancer.
MATERIALS AND METHODS
Mice
Three transgenic mouse models of mammary tumorigenesis were
used for this investigation: (1) Transgenic strain FVB.Cg-
Tg(WapHRAS)69Lln Chr Y
SJL/J (hereafter referred to as HRAS)
carries the human RAS oncogene (Harvey rat sarcoma viral
oncogene homolog) with mammary tissue-specific gene expression
driven by the Whey acidic protein (Wap) promoter (Andres et al,
1987). The HRAS strain represents a model for male mammary
cancer, since solid adenosquamous mammary carcinomas develop
only in male transgene carriers, given the integration of this
transgene on the Y Chromosome. Care was taken to confirm that
developing mammary tumours were not confused with salivary
gland tumours that also develop in this strain. (2) The transgenic
strain FVB/N-Tg(MMTV-PyVT)634Mul/J, (hereafter referred to as
PyVT) carries the Polyoma Virus middle T antigen with mammary
tissue-specific expression driven by the mouse mammary tumour
virus (MMTV) promoter (Guy et al, 1992). Virgin females that
carry the transgene develop poorly differentiated, multi-focal,
invasive ductal carcinoma by 10–12 weeks of age, with a high
incidence of lung metastases stemming from the primary
mammary tumour (Lin et al, 2003). (3) The transgenic strain
C57BL/6J-Tg(WapTAg)1Knw (hereafter referred to as WapTag1)
carries the Simian Virus 40 large T antigen (SV40 Tag) with
mammary gland-restricted expression under control of the Wap
promoter (Hu ¨sler et al, 1998). Multiparous WapTag1 females
develop late-onset mammary adenocarcinomas at 10–13 months
of age predominantly of the papillary histological type, but may
also show ductal, glandular or solid histology. Additional
information about these mammary tumour mouse models can be
obtained at the Mouse Tumor Biology Database (http://tumor.
informatics.jax.org) via the Mouse Genome Informatics website
(www.informatics.jax.org) of The Jackson Laboratory (Na ¨f et al,
2002).
All mice were produced and housed in our research colony at
The Jackson Laboratory under 14h:10h light:dark cycles. Mice
were provided with autoclaved NIH-31 diet (6% fat, 19% protein,
vitamin and mineral fortified) (Purina Mills Intl., Brentwood MO)
ad libitum and HCl-acidified water (pH2.8–3.2) ad libitum to
retard bacterial growth. Animals were weaned at 18–23 days of
age and housed in same sex groups of 3–5 in 51 in
2 (329cm
2)
polycarbonate cages containing sterilised White Pine shavings. All
animal procedures were approved by the Animal Care and Use
Committee of The Jackson Laboratory.
5-ALA preparation and administration
5-ALA.HCl (ASAT AG, Zug, Switzerland) was dissolved in sterile
saline (0.85% NaCl) immediately prior to administration, and kept
in a light-protected vial. All animals were administered a tail vein
injection of 5-ALA solution (358mM) to achieve a final dose of
200mgkg
1 of body weight. Animals were kept in their cages and
maintained in a darkened room for a 60–75min period prior to
necropsy.
Fluorescence detection
Following in vivo incubation of 5-ALA, mice were euthanised
by cervical dislocation or carbon dioxide asphyxiation. The
Figure 2 Photographic image of PpIX-stimulated red fluorescence in a
metastatic tumour derived from a PyVT strain female (15 weeks) 1h
following 200mgkg
1 ALA administration. (A) Brightfield image of isolated
bronchial tree. (B) Red fluorescence detection of a metastatic tumour in
the lung (arrow). (C) Representative H&E stained histological section of a
tumour metastases from PyVT strain females (4).
Table 1 Group size and histological characteristics of transgenic strain





size (n) Histological tumour type
HRAS M 20 Solid adenocarcinoma
PyVT F 20 Multifocal, solid adenocarcinoma
WapTag1 F 8 Papillary adenocarcinoma, glandular/
solid adenocarcinoma
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sexteriorised mammary glands were illuminated with blue light
(380–440nm) generated by a D-light system (Storz GmbH,
Tuttlingen, Germany) to excite PpIX fluorescence. Digital images
were recorded with a Leica DFX 350 camera mounted on a Wild
M10 stereo-microscope (Leica Microsystems, Bannockburn, IL,
USA) that was fitted with a 635nm emission filter provided by
Storz GmbH. Isolated lungs with mammary tumour metastasis
were imaged with a 35mm camera loaded with 160T slide film
(Eastman Kodak, Rochester, NY, USA), that was fitted with the
635nm emission filter. When fluorescent tumour foci were
p1mm in size, blue background was digitally subtracted from
the entire image to provide sufficient contrast for publication
purposes (Adobe Photoshop CS, San Jose, CA, USA).
Isolated tumour foci were fixed overnight in Bouin’s solution,
and histological sections processed for hematoxylin and eosin
(H&E) staining. For early neoplastic lesions of WapTag1
mammary glands, a minimum of 30 serial sections were examined
to confirm that no mature carcinomas were evident.
Flow cytometry
Mammary glands or palpable tumour foci from HRAS transgenic
males and PyVT transgenic females and littermate controls were
excised and minced with fine scissors in phosphate-buffered saline
(PBS) containing 2mgml
1 collagenase type IA (Sigma, St. Louis,
MO, USA). Isolated cell suspensions for flow cytometry were
generated by a 15-min-incubation in collagenase/PBS under foil
cover and disaggregration via successive aspiration through 18 and
20 gauge needles. The cell suspensions were kept on ice, under foil
wrap until fluorescence measurements with a FACSVantage SE/
DiVa flow cytometer (BD Biosciences, San Jose, CA, USA). PpIX
excitation was achieved with a 415.4nm Innova 90-2 Krypton laser.
PpIX fluorescence emissions were recorded following reflection by
a 610nm short pass dichroic mirror to a 590nm long pass filter
(Omega Optical Inc, Brattleboro, VT, USA). Acquistion and
analysis of the data for 10000 tumour cells were performed with
FACSDiva ver. 4.0, FACS Convert ver. 1.0 and CellQuestPro ver.
4.0.1 (BD Biosciences, San Jose, CA, USA).
Statistical analysis
The quantitative fluorescence flow cytometric data, representing
a minimum of three independent replicate samples, was ana-
lysed by ANOVA with Statview software (SAS Institute Inc, Cary,
NC, USA) with Po0.05 as the chosen level of statistical
significance.
Figure 3 Digital image capture of PpIX-stimulated red fluorescence in early DCIS lesions of two WapTag1 females (41 and 45 weeks) 1h following in vivo
administration of 200mgkg
1 ALA. (A, C) Red fluorescence detection of DCIS in the mammary gland. In (A) The white arrow indicates the region of DCIS,
and the black arrow indicates accumulated proteinaceous fluid. (B, D) Corresponding H&E stained histological sections (20). Scale bar represents 0.5mm.
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Mice bearing palpable mammary tumours were investigated for
their PpIX accumulation response following 5-ALA administra-
tion. Mice were euthanised and the mammary tumours exter-
iorised to examine PpIX accumulation under blue light excitation.
Mammary tumours in each of the transgenic models responded to
5-ALA administration with significant PpIX accumulation, as
measured by tumour-selective red fluorescence relative to the
normal surrounding tissues. Fluorescence was most pronounced in
PyVT mammary tumours, but was clearly evident in tumours from
each transgenic model, despite differences in histological subtype
and the gender of the tumour-bearing animal (Table 1, Figure 1).
WapTag1 tumours present with the most varied histology, but
prominent PpIX fluorescence was observed for tumours of both
papillary (Figure 1A and B) and glandular-to-solid subtypes. In
HRAS males, tumours 1–2mm in diameter were easily recognised
by red fluorescent emissions following 5-ALA treatment, with
similar solid-type histological characteristics as the larger tumour
masses (Figure 1C and D). In young PyVT females, the multiplicity
of tumour initiation within a single mammary gland was evidenced
by red fluorescence following 5-ALA administration, with some of
the foci measuring only 0.1mm (Figure 1E and F). Primary
tumours arising in PyVT transgene females frequently metastasize
to the lungs. Figure 2 shows an isolated bronchial tree with lung
metastases removed from a PyVT strain female. Under blue light,
the metastatic focus shines bright red relative to the normal lung
tissue, showing that PpIX synthesis remains upregulated in tumour
cells with metastatic competence.
Given the evidence for PpIX accumulation in palpable, mature
mammary tumours, we administered 5-ALA to WaptTag1
transgenic female mice prior to the anticipated age for palpable
tumour presentation, when early stages of tumour progression are
predicted for this mouse model. In four independent WapTag1
females, 5-ALA stimulated PpIX accumulation permitted red
fluorescence detection of areas histologically confirmed as ductal
carcinoma in situ (DCIS) with accompanying inflammation. Two
examples of PpIX stimulated red fluorescence associated with
DCIS are illustrated in Figure 3. In Figure 3A, the fluorescent
region of DCIS is adjacent to an accumulation of proteinaceous
fluid, suggesting the early tumour has stopped the flow of fluids
through the duct, while in Figure 3C, the fluorescent region is well
demarcated from the surrounding normal gland. Detection of
DCIS by PpIX fluorescence indicates that an enhanced capacity to
synthesise PpIX is a very early characteristic in the neoplastic
transition of these mammary tumours.
PpIX-stimulated fluorescence was quantified by flow cytometric
analysis in palpable (5–10mm diameter) homogeneous mammary
tumours of HRAS transgenic males and PyVT transgenic females.
A comparison of the fluorescence emitted from isolated HRAS
tumour cells derived from 5-ALA-primed vs control tumour-
bearing males is shown in Figure 4A: the HRAS tumours exposed
to 5-ALA had a significant, five-fold increase in fluorescence
emissions. Similarly, the mammary tumour cells isolated from
PyVT strain females primed with 5-ALA showed a significant,
seven-fold increase in fluorescence emissions compared to tumour
cells obtained from control animals (Figure 4B). To illustrate the
significant difference in the 5-ALA response of mammary tumors
vs the normal surrounding tissues, we also compared the PpIX
fluoresence emissions of normal mammary glands obtained from
nontransgene carrier, virgin littermates of the PyVT females. Like
the tumour cells, the normal mammary glands were either exposed
to 5-ALA (200mgkg
1) for 1h in vivo or were obtained directly
from unprimed control females. 5-ALA administration induced a
significant, two-fold increase in red fluorescence emissions in the
normal mammary gland, although this increase was significantly
less than the seven-fold increase observed in 5-ALA-primed PyVT
tumour cells, and did not interfere with the visual margins of
differential red fluorescence observed between tumour cells and
normal tissues in the intact animal (Figure 1E).
DISCUSSION
To establish whether transgenic mouse models of mammary
tumorigenesis are relevant models for human breast cancer in
terms of their response to 5-ALA, we have evaluated three well-
characterised transgenic strains that develop mammary tumours
under powerful oncogenic stimulation – HRAS, PyVT and SV40
Tag – for their ability to accumulate PpIX following administration
of 5-ALA. Our findings showed that the mammary tumours from
each transgenic strain rapidly and selectively converted 5-ALA to
PpIX, and showed five- to seven-fold enhanced fluorescence
compared with surrounding normal tissues under blue light
excitation. Similar to the primary mammary tumours, spontaneous
metastatic lesions to the lungs of tumour bearing PyVT mice were
readily demarcated by PpIX accumulation and red fluorescence
under blue light, suggesting that the cellular mechanisms
responsible for PpIX accumulation are retained within tumour
populations that acquire metastatic competence. This follows the
findings of Frei et al (2004) who found that metastatic breast
cancer cells in axillary lymph nodes of human patients could be
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Figure 4 Flow cytometric measurement of digital mean fluorescence in
PpIX-loaded tumour cells 1h following in vivo administration of
200mgkg
1 ALA (mean7s.e.). (A) Mammary tumour cells from HRAS
males. (B) Normal mammary gland and mammary tumour cells from PyVT
females.
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sPpIX accumulation in the primary tumours of each strain was
consistent, despite fundamental differences in histological subtype,
latency of onset, metastatic potential and gender of the tumour-
bearing host. Thus, the transgenic models parallel the findings for
human breast cancer cases in that the PpIX accumulation
phenotype is not selective for any particular tumour histological
subtype (Ladner et al, 2001). Most significantly, our observations
of PpIX accumulation in early DCIS of the WapTag1 transgenic
mammary glands also suggested this phenotypic switch is an early
event in the tumorigenic process. If enhanced PpIX synthesis can
similarly be utilized as an early marker for human breast cancer,
the impetus is strong to develop noninvasive imaging strategies
that take advantage of tumour cell-selective changes in PpIX
biochemistry for early detection.
A new avenue of clinical tumour imaging for human breast
cancer has opened with the availability of fiberoptic ducto-
scopy (Mokbel et al, 2005; Sauter et al, 2005). Endoscopes
of fine diameter (o1mm) inserted through the breast nipple
can gather three-dimensional structural information of the
mammary ducts, and are under investigation as a tool for
breast cancer detection. The high quality of optical imaging
allows localisation of micro-pathology, such as DCIS of the
epithelial lining within the mammary ducts. Our findings for
enhanced PpIX accumulation in early DCIS of mouse mammary
tumours suggests that fiberoptic ductoscopy combined with a
fluorescence detection system for PpIX could increase the
specificity and sensitivity of ductoscopy for early tumour detection
in the human breast.
Confirmation that mouse models of both male and female
mammary tumorigenesis parallel the clinical findings for human
breast cancer in terms of PpIX synthesis could lead to new lines of
investigation for the detection, diagnosis and therapy of breast
cancer. One advantage of the mouse models of mammary
tumorigenesis over cell culture models is that cellular events
leading to the PpIX accumulation phenotype can be genetically
and chronologically mapped according to the various stages of
tumorigenesis. Furthermore, an investigation as to whether altered
regulation of the haeme synthesis pathway is important for tumour
development can be further addressed in genetically engineered
mouse models of mammary tumorigenesis.
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